Jodi Regts | VP, Corporate Affairs and IR |
Simon Pimstone | CEO |
Ian Mortimer | President and CFO |
Stephen Willey | Stifel |
Maurice Raycroft | Jefferies |
Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2018 Xenon Pharmaceuticals Incorporated Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conference, Jodi Regts. Ma'am, you may begin.
Thanks, Heather.